Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
# Purpose of Review The present investigation is a comprehensive review regarding the use of Suvorexant for insomnia treatment. It covers the background, pathophysiology, and significance of addressing insomnia, the pharmaceutical details of Suvorexant, and its safety, efficacy, and implications in...
Saved in:
Main Authors: | Andrew H. Han, Caroline R. Burroughs, Evan P. Falgoust, Jamal Hasoon, Grace Hunt, Juyeon Kakazu, Tim Lee, Adam M. Kaye, Alan D. Kaye, Latha Ganti |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2023-01-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.67898 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
by: Noeen Sarfraz, et al.
Published: (2022-05-01) -
Daridorexant for the Treatment of Insomnia
by: Christopher L Robinson, et al.
Published: (2022-08-01) -
Zolpidem: Efficacy and Side Effects for Insomnia
by: Amber N. Edinoff, et al.
Published: (2021-06-01) -
deutetrabenazine for the treatment of chorea associated with Huntington’s disease
by: Harshit Gupta, et al.
Published: (2022-06-01) -
Brivaracetam to Treat Partial Onset Seizures in Adults
by: Dustin Latimer, et al.
Published: (2023-01-01)